EUVIMEDEUVIMED entdecken
Crossref

Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8

Shuyu Wang, Yue Chai, Jinxin Shi, Pengcheng Dai, Ruizhi Yu, Hongming Shao, Wenxin Ding, Lijuan Xu, Runhui Liu, Chunlin Zhuang

Chinese Chemical Letters · 2026-10 · 37 (10) · 112111

DOI: 10.1016/j.cclet.2025.112111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-10. Verfasst von Shuyu Wang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Second Military Medical University, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Second Military Medical University
  • National Key Research and Development Program of China

Zitieren

APA

Wang, S., Chai, Y., Shi, J., Dai, P., Yu, R., Shao, H., Ding, W., Xu, L., Liu, R., & Zhuang, C. (2026). Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8. Chinese Chemical Letters, 37(10), 112111. https://doi.org/10.1016/j.cclet.2025.112111

Vancouver

Wang S, Chai Y, Shi J, Dai P, Yu R, Shao H, et al. Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8. Chinese Chemical Letters. 2026;37(10):112111. doi:10.1016/j.cclet.2025.112111

BibTeX
@article{Wang2026,
  author = {Wang, Shuyu and Chai, Yue and Shi, Jinxin and Dai, Pengcheng and Yu, Ruizhi and Shao, Hongming and Ding, Wenxin and Xu, Lijuan and Liu, Runhui and Zhuang, Chunlin},
  title = {Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8},
  journal = {Chinese Chemical Letters},
  year = {2026},
  volume = {37},
  number = {10},
  pages = {112111},
  doi = {10.1016/j.cclet.2025.112111}
}
Kostenlos starten →